Breast Neoplasms Clinical Trial Using Trastuzumab, pertuzumab and lapatinib

- The folks at UNC Lineberger Comprehensive Cancer Center are studying the effects of Trastuzumab; pertuzumab; lapatinib on Breast Neoplasms in females ages 18 years and older. This clinical trial is slated to start September 2013 and is expected to end circa May 2016.

919-843-7197
Rachel Phipps, RN
Overall Study Contact Info
StatusName Contact Phone
RecruitingRachel Phipps, RNrachel_phipps@med.unc.edu919-843-7197

This study is officially titled, "Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib."

Locations

University of Alabama at Birmingham

Birmingham, Alabama - Recruiting

Dana Farber Cancer Institute

Boston, Massachusetts - Recruiting

Lineberger Comprehensive Cancer Center, UNC

Chapel Hill, North Carolina - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.